1Pacifici R. Cytokines, estrogen, and postmenopausal osteoporosis - thesecond decade[J]. Endocrinology, 1998,139(15): 2659 - 2661.
2Kameda T, Mano H, Yuasa T, et al. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone - resorbing osteoclasts [J]. J Exp Med,1997,186(3): 489-495.
4Delmas PD, Ensrud KE, Adachi JD, et al. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopusal women with osteoporosis:four - year results from a randomized clinical trial[J]. J Clin Endo crinol Metab, 2002,87(15) :3609 -3617.
5Russel RGG, Rogers MJ, Frith JC, et al. The pharmacology of bisphosphonates and new insights into their mechanisms of action [J]. J Bone Miner Res, 1999, 14S(1): 53-65.
7Chesnut CH, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study[J]. Am J Med, 2000,109(2): 267-276.
8Gennari C. Analgesic effect of calcitonin in osteoporosis[J]. Bone, 2002,305 (Suppl) A :67 - 70.
9Desantis A, Buchman A. Current and emerging therapies in osteoporosis [J]. Expert Opin Pharmacother, 2002, 3 4): 835 - 843.
10Samnegard E, Iwaniec CT, Cullen DM, et al. Maintenance of cortical bone in human parathyroid hormone(1-84) treated ovariectomized rats[J]. Bone,2001,28 (2): 251 - 260.
二级参考文献28
1Chesnut CH, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmcnopausal women with established osteoporosis:the prevent recurrence of osteoporotic fractures study [In Process Citation]. Am J Med, 2000,109:206-276.
2Wimalawansa SJ. Prevention and treatment of osteoponmis: efficacy of combination of hormone replacement therapy with other antiresotptive agetns. J Clin Densitiom,2000,3 : 187-190.
3Fujita T, Fujii Y, Miyauchi A, et al. Comparision of antiresorptive activivities of ipriflavone, an isoflavone derivative and eclatonin, an evolve using novel CT-like molecules. J Bone Miner Metab, 1999,17:289-295.
4Petersen MM. Effect of nasal salmon calcitonin on post-traumatic osteropenia following ankle fracture. Acta Orthop Stand, 1998,19:347-350.
5Grigoriou O. Effect of nasal administration of Calcitonin in oophorectomized Women : 2-year controlled double-blind study. Maturitas, 1997,28:147-151.
6Montemurro L, Schiraldi G, Fraioli P, et al. Prevention of corticosteroidinduced ostcoporosis with salmon calcitonin in sarcoid patients. Calcif Tissue Int, 1991,49:71.
7Moe SM. The treatment of steroid-induced bone loss in transplantation .Curr Opin Nephrol Hypertens, 1997,6(6) :544-549.
8Wallach S, Rousseau G,Martin L. Effects d calcitonin on animal and in vitro models of skeletal metabolism. Bone, 1999,25 : 509-516.
9Plotkin LI, Weinstein RS, Parfitt AM,et al. Prevention of ostoncyte and osteoblast apoptosis by bisphosphonates and calciteonin. J Clin Invest,1999,104:1363 - 1374.
10Welzel D. Analgesic potential of salmon calcitonln in postoperative pain. In:Gennari C, Segre G. eds. The effects d calcitonin in man. Proc 1st int Wkshp, Florence 1982. Masson, Milan 1983.223-302.
